Cardiac Cells
Our human cardiac cell portfolio includes a diverse collection of primary cells and stem cell-derived models representing key cellular components of the heart and cardiovascular microenvironment. From cardiomyocytes and endothelial cells to fibroblasts, stromal cells, and progenitor cells, these products support a broad range of cardiovascular research applications.
To meet different project requirements, we offer cells from multiple anatomical regions, developmental stages, and disease backgrounds, alongside flexible supply formats and customized support services.
Filter By:
Our Cardiac Cell Portfolio Highlights
-
Diverse Cardiac Cell Types
- Cardiomyocytes and iPSC-derived cardiomyocytes
- Cardiac fibroblasts, stromal cells, and progenitor cells
- Cardiac microvascular and coronary endothelial cells
-
Specialized Cardiac Models
- Fetal and adult cardiac cell populations
- Chamber-specific (atrial and ventricular) cell models
- Hypertension-associated cardiac cell models
-
Flexible Supply Options
- Ready-to-use cryopreserved cells
- Custom cell sourcing and procurement
-
Disease-Oriented Cell Selection
Assistance in identifying appropriate healthy or disease-relevant cardiac cell models for cardiovascular studies.
-
Customized Resource Sourcing
Support for donor selection, developmental-stage requirements, and specialized cardiac tissue origins.
-
Multi-Cell Study Support
Access to complementary cardiac cell populations for co-culture systems and cardiac microenvironment research.
-
Scalable Project Supply
Flexible supply options for pilot studies, long-term programs, and larger-scale cardiovascular research projects.
What types of cardiac cells are available?
Our portfolio includes cardiomyocytes, cardiac fibroblasts, cardiac stromal cells, cardiac progenitor cells, cardiac microvascular endothelial cells, coronary artery endothelial cells, pericardial fibroblasts, and aortic adventitia fibroblasts.
Do you provide disease-related cardiac cell models?
Yes. We offer disease-relevant cell models, including hypertension-associated cardiac fibroblasts and cardiac microvascular endothelial cells. Additional customized sourcing options may also be available.
Are cells available from different cardiac regions?
Yes. Certain cardiac fibroblast products are derived from specific anatomical regions, including atrial and ventricular tissues, enabling more targeted cardiovascular studies.
What quality control tests are performed?
All cardiac cells undergo rigorous quality assessment, which may include cell identity verification, viability testing, morphology evaluation, sterility testing, and mycoplasma detection.
What technical support is available?
Our scientific team can provide assistance with product selection, cell culture recommendations, experimental planning, and other technical questions related to cardiac cell applications.